Serum Circulating Free Dna of Syncytin-1 As A Novel Molecular Marker for Early Diagnosis of Non-Small-Cell Lung Cancer
Biomarkers in Medicine · 2022
DOI: 10.2217/bmm-2022-0499 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomarkers in Medicine, 2022. Verfasst von Xuewei Zhuang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Shandong Provincial Third Hospital, Shandong University, Jinan, Shandong, 250031, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Cell-Free Nucleic Acids. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Shandong Key Research and Development Program, Shandong Provincial Natural Science Foundation.
Abstract (Originalsprache)
Background
Liquid biopsy has been receiving attention as an emerging detection technology in the clinical application of non-small-cell lung cancer (NSCLC).
Methods
We quantified serum circulating free DNA (cfDNA) of syncytin-1 in 126 patients and 106 controls, analyzed the correlation of level with pathological parameters and explored diagnostic utility.
Results
The cfDNA of syncytin-1 levels in NSCLC patients were higher than healthy controls (p < 0.0001). These levels were associated with smoking history (p = 0.0393). The area under the curve of cfDNA of syncytin-1 was 0.802, and combination of cfDNA of syncytin-1/cytokeratin 19 fragment antigen 21-1/carcinoembryonic antigen markers improved diagnostic efficiency.
Conclusion
The cfDNA of syncytin-1 was detected in NSCLC patients and can be used as a novel molecular marker for early diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, Shandong Provincial Third Hospital, Shandong University, Jinan, Shandong, 250031, China.
- Department of Microbial Immune, Jinan Vocational College of Nursing, Jinan, Shandong, 250102, China.
- Department of Nursing, Shandong Provincial Third Hospital, Shandong University, Jinan, Shandong, 250031, China.
- Department of Clinical Laboratory, Shandong University Qilu Hospital, Jinan, Shandong, 250012, China.
- Department of Hepatobiliary Surgery, Shandong Provincial Third Hospital, Shandong University, Jinan, Shandong, 250031, China.
ORCID-Profile: Yong Zhang
Förderung
- Shandong Key Research and Development Program
- Shandong Provincial Natural Science Foundation
Zitieren
APA
Zhuang, X., Qian, J., Xia, X., Wang, Y., Wang, H., Jing, L., Zhang, Y., & Zhang, Y. (2022). Serum Circulating Free Dna of Syncytin-1 As A Novel Molecular Marker for Early Diagnosis of Non-Small-Cell Lung Cancer. Biomarkers in Medicine. https://doi.org/10.2217/bmm-2022-0499
Vancouver
Zhuang X, Qian J, Xia X, Wang Y, Wang H, Jing L, et al. Serum Circulating Free Dna of Syncytin-1 As A Novel Molecular Marker for Early Diagnosis of Non-Small-Cell Lung Cancer. Biomarkers in Medicine. 2022. doi:10.2217/bmm-2022-0499
BibTeX
@article{Zhuang2022,
author = {Zhuang, Xuewei and Qian, Jingrong and Xia, Xiyan and Wang, Yuanling and Wang, Hongchun and Jing, Liping and Zhang, Yanli and Zhang, Yong},
title = {Serum Circulating Free Dna of Syncytin-1 As A Novel Molecular Marker for Early Diagnosis of Non-Small-Cell Lung Cancer},
journal = {Biomarkers in Medicine},
year = {2022},
doi = {10.2217/bmm-2022-0499}
}
EUVIMED